Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection (Q37930193)

25 August 2017

Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection (English)

1 reference

25 August 2017

1 reference

Sharif Ali

1

1 reference

25 August 2017

Adrian Ormsby

2

1 reference

25 August 2017

Veena Shah

3

1 reference

25 August 2017

Maria C Segovia

4

1 reference

25 August 2017

Kristin L Kantz

5

1 reference

25 August 2017

Sharon Skorupski

6

1 reference

25 August 2017

A Bradley Eisenbrey

7

1 reference

25 August 2017

Meredith Mahan

8

1 reference

25 August 2017

Mary Ann Y Huang

9

1 reference

25 August 2017

1 September 2011

1 reference

25 August 2017

Transplant Immunology

1 reference

25 August 2017

26

1 reference

25 August 2017

1

1 reference

25 August 2017

62-69

1 reference

Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Impact of human leukocyte antigen matching in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross-Match Positive Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Plasmapheresis treatment of antibody-mediated rejection in an A2 donor to O pediatric liver transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

National conference to assess antibody-mediated rejection in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Use of C4d as a diagnostic adjunct in lung allograft biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Immunopathology of antibodies as effectors of orthotopic liver allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Soluble HLA antigens in the circulation of liver graft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

Significance of C4d staining in ABO-identical/compatible liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.08.005

10.1016/J.TRIM.2011.08.005

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference